Tuesday 7th September 2021 |
Text too small? |
Experienced retail leader Richard Umbers to join Ryman Healthcare in October
Richard Umbers has been appointed Group Chief Executive Officer at Ryman Healthcare, following an extensive global search. Mr Umbers is an internationally experienced CEO with a background in leading large businesses. His retail experience includes most recently Divisional Director of buying at supermarket retailer Kaufland in Germany, and CEO and managing director at retailer Myer in Australia. He also held senior roles at Woolworths in Australia and was managing director of Progressive Enterprises Ltd in New Zealand, now trading as Countdown supermarkets. Earlier in his career he held senior leadership roles with Australia Post and Aldi in Europe.
Mr Umbers will join Ryman in October, taking over from Gordon MacLeod, who signalled his intention to stand down earlier this year.
Ryman Healthcare Chair Dr David Kerr said Mr Umbers brings a wealth of experience in leading growth and innovation at large organisations with a strong customer focus.
“We are delighted to have secured Richard’s services and we believe he will be a great fit at Ryman.
“This is a special company with a strong culture and a team committed to the care and welfare of our residents. We believe Richard has the right mix of commercial and executive skills and qualities to continue to foster that culture and build on it to prepare Ryman for the enormous growth we see in the years ahead."
Mr Umbers is currently based in Melbourne and will join the Ryman team on October 25 and is looking forward to being based in Christchurch.
Please see the link below for details
Ryman Healthcare Limited - Media release Richard Umbers appointed Ryman Healthcare Group CEO
Source: Ryman Healthcare Limited
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors